Eliem Therapeutics (CLYM) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Eliem Therapeutics (CLYM).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 9.37M (-31.80%) | 14M (+51.49%) | 9.07M (+37.84%) | 6.58M (-62.03%) | 17M (+190.77%) | 5.96M (-4.49%) | 6.24M (+494.29%) | 1.05M (-3.67%) | 1.09M (-65.18%) | 3.13M (+8.68%) | 2.88M (-21.95%) | 3.69M (-35.49%) | 5.72M (+16.02%) | 4.93M (+15.73%) | 4.26M (-51.43%) | 8.77M (+6.17%) | 8.26M (+8.97%) | 7.58M (+26.54%) | 5.99M (+9.31%) | 5.48M (+28.34%) | 4.27M (-22.50%) | 5.51M (+185.49%) | 1.93M (+45.11%) | 1.33M | - |
Selling General And Administrative | 5.84M (+5.04%) | 5.56M (-4.47%) | 5.82M (+41.95%) | 4.10M (-27.94%) | 5.69M (+14.95%) | 4.95M (-9.84%) | 5.49M (+49.59%) | 3.67M (+92.15%) | 1.91M (-4.50%) | 2.00M (-6.10%) | 2.13M (-29.70%) | 3.03M (-82.90%) | 18M (+282.72%) | 4.63M (+3.12%) | 4.49M (-8.92%) | 4.93M (+1.23%) | 4.87M (+27.49%) | 3.82M (+12.68%) | 3.39M (+16.49%) | 2.91M (+31.08%) | 2.22M (+18.72%) | 1.87M (+503.23%) | 310K (+24.00%) | 250K | - |
Operating Expenses | 15M (-21.19%) | 19M (+29.62%) | 15M (+39.42%) | 11M (-53.61%) | 23M (+111.00%) | 11M (-6.99%) | 12M (-79.19%) | 56M (+1772.76%) | 3.01M (-41.21%) | 5.12M (+2.40%) | 5.00M (-25.48%) | 6.71M (-71.37%) | 23M (+145.45%) | 9.55M (+9.14%) | 8.75M (-36.13%) | 14M (+4.34%) | 13M (+22.71%) | 11M (+14.07%) | 9.38M (+7.69%) | 8.71M (+26.60%) | 6.88M (-59.67%) | 17M (+654.87%) | 2.26M (+40.37%) | 1.61M | - |
Depreciation And Amortization | 40K (-60.00%) | 100K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -15.21M (-21.19%) | -19.30M (+29.62%) | -14.89M (+39.42%) | -10.68M (-53.61%) | -23.02M (+111.00%) | -10.91M (-6.99%) | -11.73M (-79.19%) | -56.37M (+1779.00%) | -3.00M (-41.41%) | -5.12M (+2.40%) | -5.00M (-25.48%) | -6.71M (-71.37%) | -23.44M (+145.45%) | -9.55M (+9.14%) | -8.75M (-36.13%) | -13.70M (+4.34%) | -13.13M (+22.71%) | -10.70M (+14.07%) | -9.38M (+7.69%) | -8.71M (+26.60%) | -6.88M (-59.67%) | -17.06M (+654.87%) | -2.26M (+40.37%) | -1.61M | - |
Ebit | -15.21M (-21.19%) | -19.30M (+29.62%) | -14.89M (+39.42%) | -10.68M (-53.61%) | -23.02M (+111.00%) | -10.91M (-6.99%) | -11.73M (-79.19%) | -56.37M (+1779.00%) | -3.00M (-41.41%) | -5.12M (+2.40%) | -5.00M (-25.48%) | -6.71M (-71.37%) | -23.44M (+145.45%) | -9.55M (+9.14%) | -8.75M (-36.13%) | -13.70M (+4.34%) | -13.13M (+22.71%) | -10.70M (+14.07%) | -9.38M (+7.69%) | -8.71M (+26.60%) | -6.88M (-54.56%) | -15.14M (+569.91%) | -2.26M (+40.37%) | -1.61M (-16.15%) | -1.92M |
EBITDA | -15.17M (-34.64%) | -23.21M (+80.06%) | -12.89M (+48.67%) | -8.67M (-62.34%) | -23.02M (+39.18%) | -16.54M (+86.05%) | -8.89M (-83.80%) | -54.89M (+3128.82%) | -1.70M (-53.30%) | -3.64M (-8.31%) | -3.97M (-23.95%) | -5.22M (-76.58%) | -22.29M (+187.24%) | -7.76M (-19.83%) | -9.68M (-33.70%) | -14.60M (+10.61%) | -13.20M (+25.24%) | -10.54M (+9.68%) | -9.61M (+10.21%) | -8.72M (-53.12%) | -18.60M (+25.17%) | -14.86M (+557.52%) | -2.26M (+38.65%) | -1.63M (-15.10%) | -1.92M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 1.51M (-17.49%) | 1.83M (-10.29%) | 2.04M (-5.99%) | 2.17M (-5.24%) | 2.29M (-40.67%) | 3.86M (+38.35%) | 2.79M (+87.25%) | 1.49M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 1.51M (-17.49%) | 1.83M (-10.29%) | 2.04M (-5.99%) | 2.17M (-5.24%) | 2.29M (-40.67%) | 3.86M (+38.35%) | 2.79M (+87.25%) | 1.49M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 1.49M (-81.44%) | 8.03M (+301.50%) | 2.00M (-0.50%) | 2.01M (-10.27%) | 2.24M (-72.41%) | 8.12M (+185.92%) | 2.84M (+91.89%) | 1.48M (+12.98%) | 1.31M (-74.61%) | 5.16M (+400.97%) | 1.03M (-30.87%) | 1.49M (+29.57%) | 1.15M | -110.00K (-88.17%) | -930.00K (+4.49%) | -890.00K (+1171.43%) | -70.00K (-99.41%) | -11.81M (+5034.78%) | -230.00K (+2200.00%) | -10.00K (-99.91%) | -11.72M | 260K | - | -20.00K | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -13.72M (-21.69%) | -17.52M (+35.92%) | -12.89M (+48.67%) | -8.67M (-58.28%) | -20.78M (+146.79%) | -8.42M (-5.29%) | -8.89M (-83.80%) | -54.89M (+3128.82%) | -1.70M (-53.30%) | -3.64M (-8.31%) | -3.97M (-23.95%) | -5.22M (-76.58%) | -22.29M (+187.24%) | -7.76M (-19.83%) | -9.68M (-33.70%) | -14.60M (+10.61%) | -13.20M (+25.24%) | -10.54M (+9.68%) | -9.61M (+10.21%) | -8.72M (-53.12%) | -18.60M (+25.17%) | -14.86M (+557.52%) | -2.26M (+38.65%) | -1.63M (-15.10%) | -1.92M |
Net Income | -13.72M (-21.69%) | -17.52M (+35.92%) | -12.89M (+48.67%) | -8.67M (-58.28%) | -20.78M (+146.79%) | -8.42M (-5.29%) | -8.89M (-83.80%) | -54.89M (+3128.82%) | -1.70M (-53.30%) | -3.64M (-8.31%) | -3.97M (-23.95%) | -5.22M (-76.58%) | -22.29M (+187.24%) | -7.76M (-19.83%) | -9.68M (-33.70%) | -14.60M (+10.61%) | -13.20M (+25.24%) | -10.54M (+9.68%) | -9.61M (+10.21%) | -8.72M (-53.12%) | -18.60M (+25.17%) | -14.86M (+557.52%) | -2.26M (+38.65%) | -1.63M (-15.10%) | -1.92M |
Comprehensive Income Net Of Tax | -14.00M (-76.45%) | -59.44M (+366.56%) | -12.74M (+47.62%) | -8.63M (-57.94%) | -20.52M (-72.22%) | -73.87M (+750.06%) | -8.69M (-84.17%) | -54.89M (+3147.93%) | -1.69M (-95.14%) | -34.76M (+782.23%) | -3.94M (-23.64%) | -5.16M (-76.58%) | -22.03M (-51.56%) | -45.48M (+370.81%) | -9.66M (-34.20%) | -14.68M (+7.94%) | -13.60M (-71.43%) | -47.60M (+394.29%) | -9.63M (+10.44%) | -8.72M | - | - | - | - | - |